Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Kinase Activity Critical to Memory Formation

By LabMedica International staff writers
Posted on 02 Jul 2009
A team of Japanese neuroscientists has used advanced genetic engineering techniques to create a line of mice lacking the kinase activity in a memory-related enzyme called Ca2+/calmodulin-dependent protein kinase II-alpha (CaMKII-alpha).

CaMKII-alpha belongs to the family of multifunctional CaM kinases that are capable of carrying out several different catalytic functions. More...
They play a role in many neural processes, such as neurotransmitter secretion, transcription factor regulation, and glycogen metabolism. Between 1% and 2% of the proteins in the brain are CaM kinase II, with CaMKII-alpha being enriched in the hippocampus, the memory center of the brain. CaMKII-alpha is thought to be an essential mediator of activity-dependent synaptic plasticity and memory functions.

To study how CaMKII-alpha influences the memory process, investigators from the Japanese National Institute for Physiological Sciences (Okazaki, Japan) genetically engineered a line of mice that contained a mutant CaMKII-alpha gene. The K42R mutation caused the animals to produce CaMKII-alpha that did not have kinase activity.

Results of experiments conducted with the K42R mutant mice were published in the June 10, 2009, issue of the Journal of Neuroscience. The animals were found to produce the normal amount of CaMKII-alpha but to display as little kinase activity as a line of mice that completely lacked the CaMKII-alpha gene. The K42R mice showed a severe impairment in inhibitory avoidance learning, a form of memory that is dependent on the hippocampus.

"We demonstrated that the mutant mouse has a severe memory deficit because of the lack of the kinase activity of CaMKII-alpha. This finding supports the idea that the kinase activity of CaMKII-alpha is essential to memory functions. Such a memory-deficit mutant mouse could serve as an animal model to study the molecular mechanisms of memory, and be a useful tool for the development and screening of therapeutic reagents for memory-deficit disorders. It may also help open a new therapeutic approach to memory dysfunctions in patients,” said first author Dr. Yoko Yamagata, a researcher at the National Institute for Physiological Sciences.

Related Links:

National Institute for Physiological Sciences



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.